BACKGROUND: Due to the concentration of individuals at-risk for suicide, an emergency department visit represents an opportune time for suicide risk screening and intervention. PURPOSE: The Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE) uses a quasi-experimental, interrupted time series design to evaluate whether (1) a practical approach to universally screening ED patients for suicide risk leads to improved detection of suicide risk and (2) a multi-component intervention delivered during and after the ED visit improves suicide-related outcomes. METHODS: This paper summarizes the ED-SAFE's study design and methods within the context of considerations relevant to effectiveness research in suicide prevention and pertinent human participants concerns. 1440 suicidal individuals, from 8 general ED's nationally will be enrolled during three sequential phases of data collection (480 individuals/phase): (1) Treatment as Usual; (2) Universal Screening; and (3) Intervention. Data from the three phases will inform two separate evaluations: Screening Outcome (Phases 1 and 2) and Intervention (Phases 2 and 3). Individuals will be followed for 12 months. The primary study outcome is a composite reflecting completed suicide, attempted suicide, aborted or interrupted attempts, and implementation of rescue procedures during an outcome assessment. CONCLUSIONS: While 'classic' randomized control trials (RCT) are typically selected over quasi-experimental designs, ethical and methodological issues may make an RCT a poor fit for complex interventions in an applied setting, such as the ED. ED-SAFE represents an innovative approach to examining the complex public health issue of suicide prevention through a multi-phase, quasi-experimental design embedded in 'real world' clinical settings.
BACKGROUND: Due to the concentration of individuals at-risk for suicide, an emergency department visit represents an opportune time for suicide risk screening and intervention. PURPOSE: The Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE) uses a quasi-experimental, interrupted time series design to evaluate whether (1) a practical approach to universally screening ED patients for suicide risk leads to improved detection of suicide risk and (2) a multi-component intervention delivered during and after the ED visit improves suicide-related outcomes. METHODS: This paper summarizes the ED-SAFE's study design and methods within the context of considerations relevant to effectiveness research in suicide prevention and pertinent humanparticipants concerns. 1440 suicidal individuals, from 8 general ED's nationally will be enrolled during three sequential phases of data collection (480 individuals/phase): (1) Treatment as Usual; (2) Universal Screening; and (3) Intervention. Data from the three phases will inform two separate evaluations: Screening Outcome (Phases 1 and 2) and Intervention (Phases 2 and 3). Individuals will be followed for 12 months. The primary study outcome is a composite reflecting completed suicide, attempted suicide, aborted or interrupted attempts, and implementation of rescue procedures during an outcome assessment. CONCLUSIONS: While 'classic' randomized control trials (RCT) are typically selected over quasi-experimental designs, ethical and methodological issues may make an RCT a poor fit for complex interventions in an applied setting, such as the ED. ED-SAFE represents an innovative approach to examining the complex public health issue of suicide prevention through a multi-phase, quasi-experimental design embedded in 'real world' clinical settings.
Authors: Andrew A Nierenberg; Madhukar H Trivedi; Louise Ritz; Diane Burroughs; John Greist; Harold Sackeim; Susan Kornstein; Terry Schwartz; Diane Stegman; Maurizio Fava; Stephen R Wisniewski Journal: J Psychiatr Res Date: 2004 Nov-Dec Impact factor: 4.791
Authors: Gail D'Onofrio; Edward Jauch; Andrew Jagoda; Michael H Allen; Deirdre Anglin; William G Barsan; Rachel P Berger; Bentley J Bobrow; Edwin D Boudreaux; Cheryl Bushnell; Yu-Feng Chan; Glenn Currier; Susan Eggly; Rebecca Ichord; Gregory L Larkin; Daniel Laskowitz; Robert W Neumar; David E Newman-Toker; James Quinn; Katherine Shear; Knox H Todd; Douglas Zatzick Journal: Ann Emerg Med Date: 2010-11 Impact factor: 5.721
Authors: Catherine A Okoro; David E Nelson; James A Mercy; Lina S Balluz; Alex E Crosby; Ali H Mokdad Journal: Pediatrics Date: 2005-09 Impact factor: 7.124
Authors: Edwin D Boudreaux; Consuelo Cagande; J Hope Kilgannon; Sunday Clark; Carlos A Camargo Journal: Prim Care Companion J Clin Psychiatry Date: 2006
Authors: Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann Journal: Am J Psychiatry Date: 2011-12 Impact factor: 18.112
Authors: Marian E Betz; Sarah A Arias; Matthew Miller; Catherine Barber; Janice A Espinola; Ashley F Sullivan; Anne P Manton; Ivan Miller; Carlos A Camargo; Edwin D Boudreaux Journal: Psychiatr Serv Date: 2015-03-01 Impact factor: 3.084
Authors: Brian K Ahmedani; Christine Stewart; Gregory E Simon; Frances Lynch; Christine Y Lu; Beth E Waitzfelder; Leif I Solberg; Ashli A Owen-Smith; Arne Beck; Laurel A Copeland; Enid M Hunkeler; Rebecca C Rossom; Keoki Williams Journal: Med Care Date: 2015-05 Impact factor: 2.983
Authors: Sarah A Arias; Edwin D Boudreaux; Elizabeth Chen; Ivan Miller; Carlos A Camargo; Richard N Jones; Lisa Uebelacker Journal: Arch Suicide Res Date: 2019-06-11
Authors: Megan L Ranney; Jonathan Fletcher; Harrison Alter; Christopher Barsotti; Vikhyat S Bebarta; Marian E Betz; Patrick M Carter; Magdalena Cerdá; Rebecca M Cunningham; Peter Crane; Jahan Fahimi; Matthew J Miller; Ali Rowhani-Rahbar; Jody A Vogel; Garen J Wintemute; Muhammad Waseem; Manish N Shah Journal: Ann Emerg Med Date: 2016-12-18 Impact factor: 5.721
Authors: Sarah A Arias; Edwin D Boudreaux; Daniel L Segal; Ivan Miller; Carlos A Camargo; Marian E Betz Journal: J Am Geriatr Soc Date: 2017-07-28 Impact factor: 5.562
Authors: Marian E Betz; Mack Kautzman; Daniel L Segal; Ivan Miller; Carlos A Camargo; Edwin D Boudreaux; Sarah A Arias Journal: Psychiatry Res Date: 2017-11-14 Impact factor: 3.222
Authors: Sarah A Arias; Zi Zhang; Carla Hillerns; Ashley F Sullivan; Edwin D Boudreaux; Ivan Miller; Carlos A Camargo Journal: Suicide Life Threat Behav Date: 2014-03-03
Authors: Edwin D Boudreaux; Carlos A Camargo; Sarah A Arias; Ashley F Sullivan; Michael H Allen; Amy B Goldstein; Anne P Manton; Janice A Espinola; Ivan W Miller Journal: Am J Prev Med Date: 2015-12-04 Impact factor: 5.043